TS
RVMD icon

Thomas Steyer’s Revolution Medicines RVMD Stock Holding History

Thomas Steyer’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54B Sell
13,550,796
-54,000
-0.4% -$7.89M 11.71% 2
2026
Q1 		$1.32B Sell
13,604,796
-978,000
-7% -$98.8M 6.94% 3
2025
Q4 		$1.16B Sell
14,582,796
-42,896
-0.3% -$2.81M 5.03% 2
2025
Q3 		$683M Buy
14,625,692
+300,000
+2% +$11.7M 2.8% 9
2025
Q2 		$527M Buy
14,325,692
+791,000
+6% +$30.4M 2.21% 16
2025
Q1 		$479M Buy
13,534,692
+286,000
+2% +$11.6M 2.3% 16
2024
Q4 		$579M Buy
13,248,692
+1,931,000
+17% +$97.5M 2.54% 12
2024
Q3 		$513M Buy
11,317,692
+1,560,000
+16% +$67.9M 2.25% 13
2024
Q2 		$379M Buy
9,757,692
+2,249,820
+30% +$84.1M 1.62% 19
2024
Q1 		$242M Buy
7,507,872
+771,018
+11% +$22.9M 1.03% 29
2023
Q4 		$193M Buy
6,736,854
+3,411,374
+103% +$82M 0.88% 34
2023
Q3 		$92M Buy
3,325,480
+542,000
+19% +$16.1M 0.43% 43
2023
Q2 		$74.5M Sell
2,783,480
-500,120
-15% -$12.3M 0.37% 53
2023
Q1 		$71.1M Buy
3,283,600
+1,585,585
+93% +$39M 0.39% 53
2022
Q4 		$40.4M Sell
1,698,015
-801,985
-32% -$17.1M 0.24% 66
2022
Q3 		$49.3M Sell
2,500,000
-750,000
-23% -$16.5M 0.27% 71
2022
Q2 		$63.3M Hold
3,250,000
– – 0.34% 65
2022
Q1 		$82.9M Buy
3,250,000
+500,000
+18% +$10.9M 0.4% 54
2021
Q4 		$69.2M Hold
2,750,000
– – 0.35% 57
2021
Q3 		$75.7M Buy
2,750,000
+250,000
+10% +$7.28M 0.35% 60
2021
Q2 		$79.3M Buy
2,500,000
+890,270
+55% +$31.1M 0.32% 58
2021
Q1 		$73.9M Buy
+1,609,730
New +$72.2M 0.37% 59
2020
Q2 		– Sell
-20,733
Closed -$454K – 123
2020
Q1 		$454K Buy
+20,733
New +$574K ﹤0.01% 99

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Thomas Steyer's RVMD Position: Q2 2026 in Review

Thomas Steyer reduced its Revolution Medicines (RVMD) stake by 0.4% in Q2 2026, selling an estimated $7.89M and leaving 13,550,796 shares worth $2.54B. The position accounts for 11.71% of the portfolio, ranked #2.

Thomas Steyer first reported a position in RVMD in Q1 2020 and has held it in 23 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Thomas Steyer held 13,550,796 shares of Revolution Medicines worth $2.54B as of Q2 2026.
  • Thomas Steyer sold 54,000 Revolution Medicines shares in Q2 2026, an estimated $7.89M.
  • Revolution Medicines made up 11.71% of Thomas Steyer's portfolio in Q2 2026, its #2 holding.
  • Thomas Steyer first reported a position in Revolution Medicines in Q1 2020 and has held it in 23 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.